Going beyond CRISPR with 1 million edits per cell │ Dr. George Church
“Unlike antibody treatments that target the PCSK9 protein (an important regulator of blood cholesterol levels), which are very expensive, base editing could deliver permanent protection from hypercholesterolemia with just one dose.”